New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 22, 2014
04:55 EDTXLRN, XLRN, XLRN, XLRN, XLRNNational Kidney Foundation to hold a meeting
2014 Spring Clinical Meeting is being held in Las Vegas on April 22-26.
News For XLRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
10:46 EDTXLRNLeerink biotech analyst holds an analyst/industry conference call
Biotech Analyst Liang, along with Dr. Alan List an MDS Specialist, provide an update on the myelodysplastic syndrome pipeline on an Analyst/Industry conference call to be held on May 5 at 2:30 pm.
07:44 EDTXLRNAcceleron, Celgene select Luspatercept to advance to Phase 3
Acceleron Pharma (XLRN) announced that Acceleron and its collaboration partner, Celgene Corporation (CELG), plan to initiate a Phase 3 program with luspatercept in myelodysplastic syndromes and beta-thalassemia by year-end 2015. The companies will continue to develop sotatercept for patients with chronic kidney disease. Preliminary data from the ongoing phase 2 clinical trial of luspatercept in patients with lower risk MDS will be presented by Uwe Platzbecker, M.D., University Hospital in Dresden, Germany, in the oral session “Best of Clinical Trials II” at the MDS Foundation 13th International Symposium on Myelodysplastic Syndromes on Saturday May 2, 2015, at 10:30 AM at the Washington Marriott Wardman Park Hotel in Washington, D.C.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use